41 results
Keyword Zutectra Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Zutectra
human hepatitis B immunoglobulin, Immunization, Passive; Hepatitis B; Liver Transplantation
Date of authorisation: 30/11/2009, Revision: 15, Authorised, Last updated: 31/08/2022Zutectra Immunization Immunologic … part of the EPAR). What is Zutectra? Zutectra is a solution for injection … hepatitis-B immunoglobulin. What is Zutectra used for Zutectra is used in adults who have … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 November 2015
Last updated: 20/11/2015Zutectra … -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-26 April 2023
European Medicines Agency, Amsterdam, the Netherlands, from 24/04/2023 to 26/04/2023, Last updated: 07/07/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 February 2023
European Medicines Agency, Amsterdam, the Netherlands, from 20/02/2023 to 23/02/2023, Last updated: 24/04/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 05/07/2021 to 08/07/2021, Last updated: 10/05/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 November 2012
European Medicines Agency, London, UK, from 26/11/2012 to 29/11/2012, Last updated: 26/11/2012 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 November 2015
European Medicines Agency, London, UK, from 16/11/2015 to 19/11/2015, Last updated: 16/11/2015 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2015
European Medicines Agency, London, UK, from 06/07/2015 to 09/07/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-8 July 2016
European Medicines Agency, London, UK, from 04/07/2016 to 08/07/2016, Last updated: 04/07/2016 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 July 2015
European Medicines Agency, London, UK, from 20/07/2015 to 23/07/2015, Last updated: 03/01/2014 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 October 2015
European Medicines Agency, London, UK, from 19/10/2015 to 22/10/2015, Last updated: 03/01/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 January 2014
European Medicines Agency, London, UK, from 06/01/2014 to 09/01/2014, Last updated: 13/08/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 May 2013
European Medicines Agency, London, UK, from 13/05/2013 to 16/05/2013, Last updated: 02/07/2012 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 25/09/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 July 2017
European Medicines Agency, London, UK, from 03/07/2017 to 06/07/2017, Last updated: 13/03/2014 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 11/09/2023 -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 September 2009
CHMP, Last updated: 25/09/2009review time of 204 days. Zutectra (human hepatitis B immunoglobulin … liver failure. The review of Zutectra began on 19 November 2008 … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 April 2013
European Medicines Agency, London, UK, from 08/04/2013 to 11/04/2013, Last updated: 02/06/2012 -
List item
PRAC: Committee agendas, minutes and meeting highlights report archive 2012-2013
Last updated: 01/01/2015 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 July 2018
European Medicines Agency, London, UK, from 09/07/2018 to 12/07/2018, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 October 2015
European Medicines Agency, London, UK, from 05/10/2015 to 08/10/2015, Last updated: 13/03/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 July 2014
European Medicines Agency, London, UK, from 07/07/2014 to 10/07/2014, Last updated: 13/08/2013 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 11/10/2021 to 14/10/2021, Last updated: 20/01/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 March 2018
European Medicines Agency, London, UK, from 19/03/2018 to 22/03/2018, Last updated: 31/05/2018 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 February 2018
European Medicines Agency, London, UK, from 19/02/2018 to 22/02/2018, Last updated: 06/04/2018